C - Cyclacel Pharmaceuticals files to sell 15.2M shares for holders
2024-05-06 17:54:00 ET
More on Cyclacel Pharmaceuticals
- Cyclacel Pharmaceuticals, Inc. (CYCC) Q4 2023 Earnings Call Transcript
- Cyclacel Pharmaceuticals GAAP EPS of -$6.23 misses by $0.34
- Cyclacel Pharmaceuticals receives $2.9M R&D tax credit
- Seeking Alpha’s Quant Rating on Cyclacel Pharmaceuticals
- Historical earnings data for Cyclacel Pharmaceuticals